Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Infinity Pharmaceuticals beat estimated earnings by 13.33%, reporting an EPS of $-0.13 versus an estimate of $-0.15.
Revenue was up $174 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 4.07% drop in the share price the next day.
Here’s a look at Infinity Pharmaceuticals’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.13 | -0.13 | -0.13 | -0.14 |
| EPS Actual | -0.14 | -0.13 | -0.12 | -0.13 |
| Revenue Estimate | 340K | 300K | 520K | 280K |
| Revenue Actual | 652K | 451K | 428K | 512K |
To track all earnings releases for Infinity Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
